Cargando…

SARS-CoV-2 infection serology: a useful tool to overcome lockdown?

The outbreak of 2019 novel coronavirus disease (Covid-19) caused by SARS-CoV-2 has spread rapidly, inducing a progressive growth in infected patients number. Social isolation (lockdown) has been assessed to prevent and control virus diffusion, leading to a worldwide financial and political crisis. C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nuccetelli, Marzia, Pieri, Massimo, Grelli, Sandro, Ciotti, Marco, Miano, Roberto, Andreoni, Massimo, Bernardini, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249039/ https://www.ncbi.nlm.nih.gov/pubmed/32501411 http://dx.doi.org/10.1038/s41420-020-0275-2

Ejemplares similares

Evaluation of a new simultaneous anti-SARS-CoV-2 IgA, IgM and IgG screening automated assay based on native inactivated virus
por: Nuccetelli, Marzia, et al.
Publicado: (2021)

Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection
por: Tomassetti, Flaminia, et al.
Publicado: (2021)

The Antibodies’ Response to SARS-CoV-2 Vaccination: 1-Year Follow Up
por: Nicolai, Eleonora, et al.
Publicado: (2023)

Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects
por: Cristiano, Antonio, et al.
Publicado: (2021)

Antibody response to COVID-19 vaccine: A point of view that can help to optimize dose distribution
por: Pieri, Massimo, et al.
Publicado: (2022)

Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring
por: Cristiano, Antonio, et al.
Publicado: (2022)

How Could POCT be a Useful Tool for Migrant and Refugee Health?
por: Bernardini, Sergio, et al.
Publicado: (2021)

Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis
por: Pieri, Massimo, et al.
Publicado: (2021)

SARS-CoV-2 infection serology validation of different methods: Usefulness of IgA in the early phase of infection
por: Pieri, Massimo, et al.
Publicado: (2020)

Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies
por: Pieri, Massimo, et al.
Publicado: (2022)

The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays
por: Infantino, Maria, et al.
Publicado: (2021)

Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study
por: Cherubini, Fabio, et al.
Publicado: (2021)

Correction to: Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study
por: Cherubini, Fabio, et al.
Publicado: (2021)

Evaluation of Hepcidin Level in COVID-19 Patients Admitted to the Intensive Care Unit
por: Ciotti, Marco, et al.
Publicado: (2022)

Evaluation of the accuracy in the mucosal detection of anti-SARS-CoV-2 antibodies in nasal secretions and saliva
por: Fiorelli, Denise, et al.
Publicado: (2023)

Infection Rate of Respiratory Viruses in the Pandemic SARS-CoV-2 Period Considering Symptomatic Patients: Two Years of Ongoing Observations
por: Costanza, Gaetana, et al.
Publicado: (2022)

Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences
por: Campione, Elena, et al.
Publicado: (2021)

Post-Mortem RT-PCR Assay for SARS-CoV-2 RNA in COVID-19 Patients’ Corneal Epithelium, Conjunctival and Nasopharyngeal Swabs
por: Aiello, Francesco, et al.
Publicado: (2021)

Thymosin alpha 1 restores the immune homeostasis in lymphocytes during Post-Acute sequelae of SARS-CoV-2 infection
por: Minutolo, Antonella, et al.
Publicado: (2023)

B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications
por: Iannetta, Marco, et al.
Publicado: (2022)

Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies
por: Cristiano, Antonio, et al.
Publicado: (2021)

Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection
por: Guerrieri, Mariapia, et al.
Publicado: (2021)

T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers
por: Iannetta, Marco, et al.
Publicado: (2021)

Correction: Guerrieri et al. Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection. Vaccines 2021, 9, 1499
por: Guerrieri, Mariapia, et al.
Publicado: (2023)

Performance Evaluation of the New Chemiluminescence Immunoassay CL-1200i for HBV, HIV Panels
por: Nicolai, Eleonora, et al.
Publicado: (2023)

Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients
por: Novelli, Antonio, et al.
Publicado: (2020)

Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients
por: Amati, Francesca, et al.
Publicado: (2020)

The Gender Impact Assessment among Healthcare Workers in the SARS-CoV-2 Vaccination—An Analysis of Serological Response and Side Effects
por: Di Resta, Chiara, et al.
Publicado: (2021)

COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells
por: Latini, Andrea, et al.
Publicado: (2020)

Overcoming post-surgery challenges in lockdown
por: Morgan, Jules
Publicado: (2020)

Collaborative networks enable the rapid establishment of serological assays for SARS-CoV-2 during nationwide lockdown in New Zealand
por: McGregor, Reuben, et al.
Publicado: (2020)

Persistence of SARS-CoV-2 viral RNA in nasopharyngeal swabs after death
por: Scimeca, Manuel, et al.
Publicado: (2021)

Impact of a Nationwide Lockdown on SARS-CoV-2 Transmissibility, Italy
por: Guzzetta, Giorgio, et al.
Publicado: (2021)

Increased Mild Vaccine-Related Side Effects and Higher Specific Antibody Titers in Health Care Workers with Previous SARS-CoV-2 Infection after the mRNA BNT162b2 Vaccine
por: Ferrari, Ludovica, et al.
Publicado: (2022)

The complexities of SARS-CoV-2 serology
por: Houlihan, Catherine F, et al.
Publicado: (2020)

1139. Oral Antivirals Against SARS-CoV-2: a New Valid Strategy Against COVID-19
por: Braccialarghe, Neva, et al.
Publicado: (2022)

A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG
por: Zarletti, Gianpaolo, et al.
Publicado: (2020)

Platinum nanoparticles: an exquisite tool to overcome radioresistance
por: Li, Sha, et al.
Publicado: (2017)

Rapid System to Detect Variants of SARS-CoV-2 in Nasopharyngeal Swabs
por: Favaro, Marco, et al.
Publicado: (2023)

Smart Immunosensors for Point-of-Care Serological Tests Aimed at Assessing Natural or Vaccine-Induced SARS-CoV-2 Immunity
por: Fortunati, Simone, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_smo8o64gqjjbiourvt5i0n2l93